Neuronetics launches postpartum depression trial

July 31, 2013 by Sony Salzman

Neuronetics launches a clinical trial of its NeuroStar TMS device for treating postpartum depression.

Neuronetics launches post-partum depression trial

Neuronetics said it's enrolled 5 patients in an open-label trial of its transcranial magnetic stimulation device for treating postpartum depression.

The Malvern, Pa.-based medical device company makes the NeuroStar TMS device, designed to use a focused magnetic field to stimulate brain cells to treat depression.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp